ABO-incompatible hearts for infant transplantation

Current Opinion in Organ Transplantation

Volumn 16, Issue 5, 2011, Pages 548-554

  West, Lori J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

ABO blood groups; antibodies; immune tolerance; listing strategies

Indexed keywords

AZATHIOPRINE; BORTEZOMIB; CARBOHYDRATE ANTIGEN; CYCLOSPORIN; ECULIZUMAB; HEMAGGLUTININ; HLA ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS;

ANTIBODY MEDIATED REJECTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CARDIOPULMONARY BYPASS; CARDIOVASCULAR RISK; COMPLEMENT ACTIVATION; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HIGH RISK INFANT; HOSPITAL ADMISSION; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNOBIOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFANCY; PATIENT SAFETY; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; REVIEW;

ABO BLOOD-GROUP SYSTEM; DONOR SELECTION; EUROPE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; INCIDENCE; INFANT; UNITED STATES;

EID: 81155161051     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32834a97a5     Document Type: Review

References (44)

1. Kirk R, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirteenth official pediatric heart transplantation report-2010. J Heart Lung Transplant 2010; 29:1119-1128.
2. Everitt MD, Donaldson AE, Casper TC, et al. Effect of ABO-incompatible listing on infant heart transplant waitlist outcomes: analysis of the United Network forOrgan Sharing (UNOS) database. J Heart Lung Transplant 2009; 28:1254-1260.
3. Almond CS, Gauvreau K, Thiagarajan RR, et al. Impact of ABO-incompatible listing on wait-list outcomes among infants listed for heart transplantation in the United States: a propensity analysis. Circulation 2010; 121:1926-1933.
4. Boucek MM. Breaching the barrier of ABO incompatibility in heart transplantation for infants. N Engl J Med 2001; 344:843-844. (Pubitemid 32222165)
5. Cooper DK. Clinical survey of heart transplantation between ABO blood group-incompatible recipients and donors. J Heart Transplant 1990; 9:376-381. (Pubitemid 20279764)
6. Tanabe K, Takahashi K, Agishi T, et al. Removal of anti-A/B antibodies for successful kidney transplantation between ABO blood type incompatible couples. Transfus Sci 1996; 17:455-462.
7. Fong SW, Qaqundah BY, Taylor WF. Developmental patterns of ABO isoagglutinins in normal children correlated with the effects of age, sex, and maternal isoagglutinins. Transfusion 1974; 14:551-559.
8. West LJ, Pollock-Barziv SM, Dipchand AI, et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001; 344:793-800. (Pubitemid 32222156)
9. Foreman C, Gruenwald C, West L. ABO-incompatible heart transplantation: a perfusion strategy. Perfusion 2004; 19:69-72. (Pubitemid 38386652)
10. West LJ, Karamlou T, Dipchand AI, et al. Impact on outcomes after listing and transplantation, of a strategy to accept ABO blood group-incompatible donor hearts for neonates and infants. J Thorac Cardiovasc Surg 2006; 131:455-461. (Pubitemid 43121571)
11. McMahon AM, van Doorn C, Burch M, et al. Improved early outcome for endstage dilated cardiomyopathy in children. J Thorac Cardiovasc Surg 2003; 126:1781-1787. (Pubitemid 38020734)
12. Rao JN, Hasan A, Hamilton JR, et al. ABO-incompatible heart transplantation in infants: the Freeman Hospital experience. Transplantation 2004; 77:1389-1394. (Pubitemid 38668433)
13. Schmoeckel M, Dabritz SH, Kozlik-Feldmann R, et al. Successful ABO-incompatible heart transplantation in two infants. Transpl Int 2005; 18:1210-1214. (Pubitemid 41726766)
14. Daebritz SH, Schmoeckel M, Mair H, et al. Blood type incompatible cardiac transplantation in young infants. Eur J Cardiothorac Surg 2007; 31:339-343; discussion 343. (Pubitemid 46329383)
15. Rodriguez RJ, Addonizio LJ, Lamour JM, et al. Pediatric heart transplantation across ABO blood type barriers: a case study. Prog Transplant 2005; 15:161-165.
16. Gambino A, Torregrossa G, Cozzi E, et al. ABO-incompatible heart transplantation: crossing the immunological barrier. J Cardiovasc Med (Hagerstown) 2008; 9:854-857.
17. Roche SL, Burch M, O'Sullivan J, et al. Multicenter experience of ABOincompatible pediatric cardiac transplantation. Am J Transplant 2008; 8:208-215.
18. Fan X, Ang A, Pollock-Barziv SM, et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 2004; 10:1227-1233. (Pubitemid 39540440)
19. Urschel S, Dalla Pozza R, Loeff M, et al. Successful ABO-incompatible heart transplantation in a child despite blood-group sensitization after ventricular assist device support. Pediatr Transplant 2009; 13:773-776.
20. Patel ND, Weiss ES, Scheel J, et al. ABO-incompatible heart transplantation in infants: analysis of the united network for organ sharing database. J Heart Lung Transplant 2008; 27:1085-1089.
21. Dipchand AI, Pollock BarZiv SM, Manlhiot C, et al. Equivalent outcomes for pediatric heart transplantation recipients: ABO-blood group incompatible versus ABO-compatible. Am J Transplant 2010; 10:389-397.
22. Irving C, Parry G, Cassidy J, et al. Outcomes following infant listing for cardiac transplantation: the impact of strategies introduced to counteract limited donor availability. Arch Dis Child 2010; 95:883-887.
23. Saczkowski R, Dacey C, Bernier PL. Does ABO-incompatible and ABOcompatible neonatal heart transplant have equivalent survival? Interact Cardiovasc Thorac Surg 2010; 10:1026-1033.
24. Chopek MW, Simmons RL, Platt JL. ABO-incompatible kidney transplantation: initial immunopathologic evaluation. Transplant Proc 1987; 19:4553-4557. (Pubitemid 18049660)
25. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11:450-456.
26. Narayanan K, Jendrisak MD, Phelan DL, Mohanakumar T. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway. Transpl Immunol 2006; 15:187-197. (Pubitemid 43129385)
27. Lynch RJ, Platt JL. Accommodation in organ transplantation. Curr Opin Organ Transplant 2008; 13:165-170. (Pubitemid 351374255)
28. Economidou J, Hughes-Jones NC, Gardner B. Quantitative measurements concerning A and B antigen sites. Vox Sang 1967; 12:321-328.
29. Gloor JM, Lager DJ, Moore SB, et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003; 75:971-977. (Pubitemid 36438524)
30. West LJ, Platt JL. And justice for all: consideration of ABO compatibility in allocation of hearts for infant transplantation. Circulation 2010; 121:1884-1886.
31. West LJ. Lost in regulation: why do U.S. policies for ABO-incompatible transplantation for infants lag behind? J Heart Lung Transplant 2009; 28:1246-1248.
32. Bucin D, Johansson S, Lindberg LO. Heart transplantation across antibodies against human leukocyte antigen and ABO-posttransplant follow-up of donor reactive antibodies. Xenotransplantation 2006; 13:101-104.
33. Genberg H, Kumlien G, Wennberg L, Tyden G. The efficacy of antigen-specific immunoadsorption and rebound of anti-A/B antibodies in ABO-incompatible kidney transplantation. Nephrol Dial Transplant 2011; 26:2394-2400.
34. Stegall MD, Dean PG, Gloor J. Mechanisms of alloantibody production in sensitized renal allograft recipients. Am J Transplant 2009; 9:998-1005.
35. Stegall MD, Gloor JM. Deciphering antibody-mediated rejection: new insights into mechanisms and treatment. Curr Opin Organ Transplant 2010; 15:8-10.
36. Everly MJ, Terasaki PI, Hopfield J, et al. Protective immunity remains intact after antibody removal by means of proteasome inhibition. Transplantation 2010; 90:1493-1498.
37. Everly MJ, Everly JJ, Susskind B, et al. Bortezomib provides effective therapy for antibody-and cell-mediated acute rejection. Transplantation 2008; 86:1754-1761.
38. Perry DK, Burns JM, Pollinger HS, et al. Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production. Am J Transplant 2009; 9:201-209.
39. Locke JE, Magro CM, Singer AL, et al. The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. Am J Transplant 2009; 9:231-235.
40. Hasegawa Y, Kato Y, Kaneko MK, et al. Neutralization of blood group Aantigen by a novel anti-A antibody: overcoming ABO-incompatible solid-organ transplantation. Transplantation 2008; 85:378-385. (Pubitemid 351322761)
41. Kobayashi T, Liu D, Ogawa H, et al. Removal of blood group A/B antigen in organs by ex vivo and in vivo administration of endo-beta-galactosidase (ABase) for ABO-incompatible transplantation. Transpl Immunol 2009; 20:132-138.
42. Meloncelli PJ, West LJ, Lowary TL. Synthesis and NMR studies on the ABO histo-blood group antigens: synthesis of type III and IV structures and NMR characterization of type I-VI antigens. Carbohydr Res 2011; 346:1406-1426.
43. Slaney AM, Wright VA, Meloncelli PJ, et al. Biocompatible carbohydratefunctionalized stainless steel surfaces: a new method for passivating biomedical implants. ACS Appl Mater Interfaces 2011; 3:1601-1612.
44. Urschel S, Campbell PM, Meyer SR, et al. Absence of donor-specific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age? Am J Transplant 2010; 10:149-156.